Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Europeans Jointly Promote Future Use of Data from Electronic Health Records for Research

13.01.2012
TMF workshop on ethical and legal aspects of cross-border secondary use of treatment data

Up to 2014, within the scope of the European project "Electronic Health Records for Clinical Research" (EHR4CR), partners from academic research and industry will be jointly establishing a Europe-wide technology platform that aims to allow secondary use of data from electronic health records for the purpose of clinical research.

Today, lawyers, ethics specialists, and data protection experts from various EU member states are discussing in Berlin what legal and ethical issues will have to be addressed. The workshop is being organized by TMF, which – due to its extensive preliminary work on data protection and ethical issues of networked medical research – in this project is leading a work package dealing with the topic of data protection and data security.

Secondary use of data from electronic health records for the purpose of medical research could cut costs, speed up clinical research projects and make them more efficient. In particular, researchers could better identify suitable study patients – hitherto one of the major difficulties in planning and conducting clinical studies. Now a technological platform is to be created which will seamlessly integrate electronic health records into existing research platforms and networks in the health sector.

Legal Regulations in the EU Countries Vary Considerably

However, many legal and ethical issues still have to be clarified on the way. In particular, one of the reasons why the legal framework to which physicians, researchers and patients are exposed in the cross-border use of patient data for clinical research is uncertain is that the legal regulations and implemented legal practice concerning data protection and protection of the private domain vary substantially throughout the individual EU member states. For this reason, one work package in the EHR4CR project has the task of analyzing the current legal situations in the various member states of the EU and comparing them with one another. The aim is to provide recommendations as to how legal certainty can be created for clinical research when using the EU-wide technology platform.

At the workshop in Berlin on January 12 and 13, 2012, the legal situation in selected pilot countries is being presented: France, Great Britain, Scotland, and Germany. European researchers, lawyers and data protectionists will be jointly examining what points on the pathway of data from clinics to research are critical in legal terms.

One of the Largest Public-Private Partnership Projects in Europe

The EHR4CR project is being funded with a total of 17 million euros within the scope of the Innovative Medicines Initiative (IMI) over the period from 2011 to 2014. IMI is one of the largest public-private partnership projects in Europe with the aim of speeding up the development of better and safer medicinal drugs. The initiative is being jointly funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Antje Schütt | idw
Further information:
http://www.ehr4cr.eu/
http://www.imi.europa.eu/

More articles from Seminars Workshops:

nachricht EMBO-Workshop on SMC proteins at the IMP Vienna
12.05.2015 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH

nachricht UKP-Workshop: Ultrafast Laser Technology 2015 - Productivity is the key
08.05.2015 | Fraunhofer-Institut für Lasertechnik ILT

All articles from Seminars Workshops >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Basel Physicists Develop Efficient Method of Signal Transmission from Nanocomponents

Physicists have developed an innovative method that could enable the efficient use of nanocomponents in electronic circuits. To achieve this, they have developed a layout in which a nanocomponent is connected to two electrical conductors, which uncouple the electrical signal in a highly efficient manner. The scientists at the Department of Physics and the Swiss Nanoscience Institute at the University of Basel have published their results in the scientific journal “Nature Communications” together with their colleagues from ETH Zurich.

Electronic components are becoming smaller and smaller. Components measuring just a few nanometers – the size of around ten atoms – are already being produced...

Im Focus: IoT-based Advanced Automobile Parking Navigation System

Development and implementation of an advanced automobile parking navigation platform for parking services

To fulfill the requirements of the industry, PolyU researchers developed the Advanced Automobile Parking Navigation Platform, which includes smart devices,...

Im Focus: First electrical car ferry in the world in operation in Norway now

  • Siemens delivers electric propulsion system and charging stations with lithium-ion batteries charged from hydro power
  • Ferry only uses 150 kilowatt hours (kWh) per route and reduces cost of fuel by 60 percent
  • Milestone on the road to operating emission-free ferries

The world's first electrical car and passenger ferry powered by batteries has entered service in Norway. The ferry only uses 150 kWh per route, which...

Im Focus: Into the ice – RV Polarstern opens the arctic season by setting course for Spitsbergen

On Tuesday, 19 May 2015 the research icebreaker Polarstern will leave its home port in Bremerhaven, setting a course for the Arctic. Led by Dr Ilka Peeken from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) a team of 53 researchers from 11 countries will investigate the effects of climate change in the Arctic, from the surface ice floes down to the seafloor.

RV Polarstern will enter the sea-ice zone north of Spitsbergen. Covering two shallow regions on their way to deeper waters, the scientists on board will focus...

Im Focus: Gel filled with nanosponges cleans up MRSA infections

Nanoengineers at the University of California, San Diego developed a gel filled with toxin-absorbing nanosponges that could lead to an effective treatment for skin and wound infections caused by MRSA (methicillin-resistant Staphylococcus aureus), an antibiotic-resistant bacteria. This "nanosponge-hydrogel" minimized the growth of skin lesions on mice infected with MRSA - without the use of antibiotics. The researchers recently published their findings online in Advanced Materials.

To make the nanosponge-hydrogel, the team mixed nanosponges, which are nanoparticles that absorb dangerous toxins produced by MRSA, E. coli and other...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International symposium: trends in spatial analysis and modelling for a more sustainable land use

20.05.2015 | Event News

15th conference of the International Association of Colloid and Interface Scientists

18.05.2015 | Event News

EHFG 2015: Securing health in Europe. Balancing priorities, sharing responsibilities

12.05.2015 | Event News

 
Latest News

Mesoporous Particles for the Development of Drug Delivery System Safe to Human Bodies

22.05.2015 | Materials Sciences

Computing at the Speed of Light

22.05.2015 | Information Technology

Development of Gold Nanoparticles That Control Osteogenic Differentiation of Stem Cells

22.05.2015 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>